Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04626791
Title Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Academic and Community Cancer Research United
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Ochsner NCI Community Oncology Research Program WITHDRAWN New Orleans Louisiana 70121 United States Details
Metropolitan-Mount Sinai Medical Center WITHDRAWN Minneapolis Minnesota 55404 United States Details
Mount Sinai Hospital ACTIVE_NOT_RECRUITING New York New York 10029 United States Details
Carolinas Medical Center/Levine Cancer Institute RECRUITING Charlotte North Carolina 28203 United States Details
Fred Hutchinson Cancer Research Center WITHDRAWN Seattle Washington 98109 United States Details
University of Washington Medical Center - Montlake RECRUITING Seattle Washington 98195 United States Details
Aurora Cancer Care-Milwaukee West WITHDRAWN Wauwatosa Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field